What is Echopixel?
Echopixel, Inc. is a pioneer in the digital health space, specializing in advanced visualization solutions that bridge the gap between standard medical imaging and actionable clinical insights. The company's flagship platform empowers physicians to interact with patient-specific digital twins, effectively transforming 2D data into 4D interactive holograms. This capability is critical for addressing the inherent challenges of visualizing 3D anatomical relationships, particularly in structural and congenital heart programs. With FDA 510k clearance, the platform is currently deployed in leading medical institutions, serving as a vital tool for surgical planning and intra-operative guidance. By digitizing the patient anatomy, Echopixel is fundamentally altering the standard of care, reducing procedural uncertainty and enhancing patient outcomes through precision health innovation.
How much funding has Echopixel raised?
Echopixel has raised a total of $19.7M across 6 funding rounds:
Unspecified
$1M
Angel/Seed
$2.4M
Unspecified
$1.8M
Private Equity
$6M
Series A
$8.5M
Debt
$150K
Unspecified (2012): $1M, investors not publicly disclosed
Angel/Seed (2013): $2.4M, investors not publicly disclosed
Unspecified (2016): $1.8M supported by AutoTech Ventures and Aurus Capital
Private Equity (2017): $6M featuring Aurus and 180 Degree Capital Corp
Series A (2017): $8.5M backed by LAM Research, Binomial Ventures, 180 Degree Capital Corp, Intel Capital, Aurus Capital, and Runa Capital
Debt (2020): $150K with participation from PPP
Key Investors in Echopixel
Intel Capital
A division of Intel, this firm invests in innovative startups targeting artificial intelligence, cloud computing, and next-generation compute technologies.
Runa Capital
An international venture capital firm that focuses on deep tech and software, with a growing emphasis on quantum technologies and high-growth enterprise solutions.
Aurus Capital
A leading venture investment firm in Latin America that leverages its robust network to support high-performance entrepreneurial teams in the technology and life sciences sectors.
What's next for Echopixel?
With the recent capital deployment, Echopixel is well-positioned to accelerate its market penetration and expand its software ecosystem. The strategic focus will likely shift toward deepening the integration of its 4D visualization tools within existing hospital workflows and exploring new therapeutic applications for its digital twin technology. As the company scales, it will leverage its robust intellectual property portfolio and established clinical partnerships to maintain its competitive edge in the rapidly evolving medical imaging market. Future growth will be driven by the continued adoption of its precision health solutions, as the firm seeks to capitalize on the increasing demand for high-fidelity, interactive diagnostic tools in complex surgical environments.
See full Echopixel company page
